| 4742- | SSE, | Antitumor Effects of Selenium |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | Sepsis, | NA |
| 4741- | SSE, | Selenium in Oncological Intervention |
| - | Review, | Var, | NA |
| 4740- | SSE, | Optimising Selenium for Modulation of Cancer Treatments |
| - | Review, | Var, | NA |
| 4728- | SSE, | Selective Impact of Selenium Compounds on Two Cytokine Storm Players |
| - | NA, | Covid, | NA |
| 4716- | SSE, | Selenium Substitution During Radiotherapy of Solid Tumours – Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients |
| - | in-vivo, | HNSCC, | NA |
| 4723- | SSE, | Selenium Induces Ferroptosis in Colorectal Cancer Cells via Direct Interaction with Nrf2 and Gpx4 |
| - | in-vitro, | CRC, | HCT116 |
| 4733- | SSE, | Selenium supplementation of lung epithelial cells enhances nuclear factor E2-related factor 2 (Nrf2) activation following thioredoxin reductase inhibition |
| - | NA, | Nor, | NA |
| 4732- | SSE, | Selenium inhibits ferroptosis and ameliorates autistic-like behaviors of BTBR mice by regulating the Nrf2/GPx4 pathway |
| - | in-vivo, | Autism, | NA |
| 4731- | SSE, | Dietary selenium mitigates cadmium-induced apoptosis and inflammation in chicken testicles by inhibiting oxidative stress through the activation of the Nrf2/HO-1 signaling pathway |
| - | in-vivo, | Nor, | NA |
| 4718- | SSE, | High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer |
| - | in-vitro, | Ovarian, | NA |
| 4750- | SSE, | Rad, | Selenium in Radiation Oncology—15 Years of Experiences in Germany |
| - | Review, | Var, | NA |
| 4753- | SSE, | Chemo, | Selenium and Lung Cancer: A Systematic Review and Meta Analysis |
| - | Review, | Lung, | NA |
| 5081- | SSE, | Application Notes and Protocols: Selenite as a Selenium Source in Cell Culture Media Supplementation |
| - | Review, | Var, | NA |
| 5080- | SSE, | Sodium Selenite Regulates the Proliferation and Apoptosis of Gastric Cancer Cells by Suppressing the Expression of LncRNA HOXB-AS1 |
| - | in-vitro, | GC, | HGC27 | - | in-vitro, | GC, | NCI-N87 |
| 5079- | SSE, | Rad, | The solvent and treatment regimen of sodium selenite cause its effects to vary on the radiation response of human bronchial cells from tumour and normal tissues |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | BEAS-2B |
| 5078- | SSE, | Rad, | Results from a Phase 1 Study of Sodium Selenite in Combination with Palliative Radiation Therapy in Patients with Metastatic Cancer |
| - | Trial, | Pca, | NA |
| 5077- | SSE, | Antitumor effects of sodium selenite on acute lymphocytic leukemia |
| - | in-vitro, | AML, | NA |
| 5076- | SSE, | Sodium selenite inhibits the growth of cervical cancer cells through the PI3K/AKT pathway |
| - | in-vivo, | Cerv, | HeLa | - | in-vivo, | Cerv, | SiHa |
| 5075- | SSE, | Sodium selenite inhibits proliferation and metastasis through ROS‐mediated NF‐κB signaling in renal cell carcinoma |
| - | vitro+vivo, | RCC, | 786-O |
| 5074- | SSE, | Application of Sodium Selenite in the Prevention and Treatment of Cancers |
| - | Review, | Var, | NA |
| 5073- | SSE, | Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study |
| - | Trial, | Var, | NA |
| 5091- | SSE, | Superoxide-mediated ferroptosis in human cancer cells induced by sodium selenite |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | CRC, | HT-29 | - | in-vitro, | Nor, | SVGp12 |
| 5093- | SSE, | Pharmacological mechanisms of the anticancer action of sodium selenite against peritoneal cancer in mice |
| - | in-vivo, | Var, | NA |
| 5111- | SSE, | Sodium selenite induces apoptosis via ROS-mediated NF-κB signaling and activation of the Bax-caspase-9-caspase-3 axis in 4T1 cells |
| - | in-vitro, | BC, | 4T1 |
| 5110- | SSE, | Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells |
| - | in-vitro, | AML, | APL NB4 |
| 5109- | SSE, | Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells |
| - | in-vitro, | CRC, | HCT116 |
| 5108- | SSE, | Activation of p53 by sodium selenite switched human leukemia NB4 cells from autophagy to apoptosis |
| - | in-vitro, | AML, | U937 |
| 5107- | SSE, | Involvement of p38 in signal switching from autophagy to apoptosis via the PERK/eIF2α/ATF4 axis in selenite-treated NB4 cells |
| - | vitro+vivo, | AML, | APL NB4 |
| 5106- | SSE, | GSH, | Dual role of glutathione in selenite-induced oxidative stress and apoptosis in human hepatoma cells |
| - | in-vitro, | Liver, | HepG2 |
| 5105- | SSE, | Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells |
| - | in-vitro, | Pca, | LNCaP |
| 5097- | SSE, | Examining xCT-mediated selenium uptake and selenoprotein production capacity in cells |
| - | in-vitro, | Var, | NA |
| 5096- | SSE, | Selenium Toxicity Accelerated by Out-of-Control Response of Nrf2-xCT Pathway |
| - | in-vitro, | BC, | MCF-7 |
| 5095- | SSE, | Extracellular thiol-assisted selenium uptake dependent on the xc− cystine transporter explains the cancer-specific cytotoxicity of selenite |
| - | in-vitro, | Lung, | H157 |
| 5094- | SSE, | Sodium Selenite Prevents Matrine-Induced Nephrotoxicity by Suppressing Ferroptosis via the GSH-GPX4 Antioxidant System |
| - | vitro+vivo, | Nor, | NRK52E |
| 5082- | SSE, | Rationale for the treatment of cancer with sodium selenite |
| - | Review, | Var, | NA |
| 5092- | SSE, | Redox-Active Selenium Compounds—From Toxicity and Cell Death to Cancer Treatment |
| - | Review, | Var, | NA |
| 5112- | SSE, | https://pubmed.ncbi.nlm.nih.gov/19811770/ |
| - | in-vitro, | Pca, | PC3 |
| 5090- | SSE, | Sodium Selenite Induces Ferroptosis in Non-small Cell Lung Cancer A549 Cells Via Reactive Oxygen Species (ROS)/Glutathione (GSH)/Glutathione Peroxidase4 (GPx4) Axis |
| - | NA, | Lung, | A549 |
| 5089- | SSE, | Se, | Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line |
| - | in-vitro, | Pca, | LNCaP |
| 5088- | SSE, | Superoxide-mediated ferroptosis in human cancer cells induced by sodium selenite |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | GBM, | U87MG | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | GBM, | A172 |
| 5087- | SSE, | Sodium Selenite Alleviates Breast Cancer-Related Lymphedema Independent of Antioxidant Defense System |
| - | Trial, | BC, | NA |
| 5086- | SSE, | Sodium Selenite Induces Superoxide-Mediated Mitochondrial Damage and Subsequent Autophagic Cell Death in Malignant Glioma Cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | T98G | - | in-vitro, | GBM, | A172 |
| 5085- | SSE, | Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites |
| - | Review, | Var, | NA |
| 5084- | SSE, | GEM, | The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study |
| - | in-vitro, | PC, | PANC1 | - | vitro+vivo, | PC, | Panc02 |
| 5083- | SSE, | Sodium Selenite as an Anticancer Agent |
| - | Review, | Var, | NA |
| 4500- | SSE, | Dietary selenium affects host selenoproteome expression by influencing the gut microbiota |
| - | in-vivo, | Nor, | NA |
| 4610- | SSE, | Rad, | Protection during radiotherapy: selenium |
| - | Review, | Var, | NA |
| 4498- | SSE, | Selenium in Human Health and Gut Microflora: Bioavailability of Selenocompounds and Relationship With Diseases |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | IBD, | NA |
| 4497- | SSE, | Selenium and inflammatory bowel disease |
| - | Review, | Var, | NA | - | Review, | IBD, | NA |
| 4494- | SSE, | Advances in the study of selenium and human intestinal bacteria |
| - | Review, | IBD, | NA | - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid